RxDoctor Payments DataLook up a doctor →

Stephen Little, MD

Cardiovascular Disease · Houston, TXNPI 1659412336

Payments from drug & device makers

$806,433in general payments, 2019–2025

Across 355 payments — averaging $2271.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$635K
  • Siemens Medical Solutions USA, Inc.$92K
  • Medtronic$75K
  • Edwards Lifesciences$3K
  • Boston Scientific$161
  • GE HealthCare$145
  • plus $645 from 14 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$806,433 in reported general payments places this provider in the 95th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas

Medicare billing

Part B allowed, 2024
$117,974
Medicare patients
950
Services billed
1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →